China Sky One Medical, Inc. Signs Agreement with Taiwan Golden Biotechnology Corp. on Development of New Anti-C... ( HARBIN China May 21 Asia-FirstCal...)

HOME >> BIOLOGY >> TECHNOLOGY

China Sky One Medical, Inc. Signs Agreement with Taiwan Golden Biotechnology Corp. on Development of New Anti-Cancer Drug

Date:5/21/2009

HARBIN, China, May 21 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced that it signed an agreement with Taiwan Golden Biotechnology Corporation to begin cooperating on the development of a new anti-cancer drug called Antroquinonol.

Golden Biotechnology Corporation specializes in the development of new bio-medicines based on its research in the fields of modern biotechnology and molecular medicine. Antroquinonol is a kind of compound extracted from Antrodia Cinnamomea Chang & Chou, a rare medicinal fungus that grows naturally inside the Cinnamonum kanehirae tree trunk, a native tree species of Taiwan. It can be used in the treatment of liver cancer and lung cancer.

The so called "King of Medical Fungi" and "Ruby of Taiwan's Forest," Antrodia Cinnamomea Chang & Chou has been widely used by the Taiwanese since it can eliminate toxins, protect the liver, improve the immune system, fight allergies, and reduce blood fat. Golden Biotechnology Corporation's research department accidentally discovered Antroquinonol when it was studying the efficacy of the extract from Antrodia Cinnamomea Chang & Chou. In further study, Antroquinonol has been proven to restrain the growth and reproduction of cancer cells, thought the existing extracts take effect slowly due to low concentration of Antroquinonol. Through sophisticated extraction techniques, Golden Biotechnology Corporation acquired pure Antroquinonol, which has been granted patents in 60 countries. Pre-clinical research on Antroquinonol has been completed in the United Kingdom and in the United States the compound has been approved by the U.S. FDA to enter into first stage clinical tri
'/>"/>

0

GOOD

Page: 1 2 3
Related biology technology :

1. The Hamner Institutes Announce Partnership With China Medical City
2. China Sky One Medical, Inc. Appoints Pricewaterhouse Coopers to Help Develop a SOX 404 Compliance Program
3. Solvay Pharmaceuticals Announces Strategic Partnership With HUYA to Access new Drug Candidates From China
4. China Biologic Products Announces Strong First Quarter 2009 Results
5. China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results
6. China Biologic Products Announces 2009 First Quarter Results Conference Call
7. China Biologic Products to Present at CCG IRs China Rising Conference and Oppenheimers China Dragon Call Conference in New York
8. China Sky One Medical, Inc. Schedules Conference Call to Discuss First Quarter 2009 Results
9. China-Biotics, Inc. to Present at CCG Investor Relations China Rising Conference
10. China Biologic Products Receives $5.3 Million Order from Largest Biopharmaceutical Distributor in India
11. China Medical Technologies Receives SFDA Approval for Its Bladder Cancer FISH Probe

Post Your Comments:

China Sky One Medical, Inc. Signs Agreement with Taiwan Golden Biotechnology Corp. on Development of New Anti-C...( HARBIN China May 21 Asia-FirstCal...)